The Advanced Ovarian Cancer Treatment Palette: Candid Conversations on PARP Inhibitors

Upgrading the Treatment Algorithm for Advanced Ovarian CancerПодробнее

Ovarian Cancer: PARP Inhibitors and Beyond (Webinar) May 8th World Ovarian Cancer DayПодробнее

Sequencing PARP Inhibitors in Advanced Ovarian CancerПодробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChatПодробнее

Expert report on survival data from pivotal trials with PARP inhibitors for BRCA-mut. Ovarian CancerПодробнее

Updates in Treatment of Ovarian Cancer: PARP InhibitorsПодробнее

Evaluating future use of PARP inhibitors in neoadjuvant therapy for ovarian cancerПодробнее

Enhancing Personalized Medicine in Ovarian Cancer: Advances in PARP Inhibition and Novel ModalitiesПодробнее

Dr. Secord on the Role of PARP Inhibitors in Ovarian CancerПодробнее

PARP Inhibitors’ Impact on Advanced Ovarian CancerПодробнее

Assessing the role of PARP inhibitors and immunotherapy in ovarian cancerПодробнее

Michael Birrer, MD, on the key takeaways from the ovarian plenary session in ovarian cancerПодробнее

The PARP Revolution: How PARP inhibitors are changing the landscape of ovarian cancer treatmentПодробнее

PARP Inhibitors in Advanced Ovarian CancerПодробнее

Dr. Penson on the Eligibility Criteria for PARP Inhibitors in Advanced Ovarian CancerПодробнее

A Webinar on PARP Inhibitors in Epithelial Ovarian CancerПодробнее

PARP Inhibitors in Recurrent Ovarian CancerПодробнее

PARP Inhibitors in Ovarian Cancer Treatment | Webinar | Ambry GeneticsПодробнее